Nurse Practitioner, Family · Bluffton, IN
NPI
1467630061
Since 2008
Specialty
Nurse Practitioner, Family
Code 363LF0000X
Group practices
0
Medicare group memberships
Hospitals
0
Hospital affiliations
1115 S Main St
Bluffton, IN, 46714
Phone (260) 824-1071
Medicare paid, 2024
$8,324
244 services
Medicare patients, 2024
62
Average age 54
Drug cost, 2024
$2.7M
5,272 prescriptions
Company payments, 2025
$1,849
From 16 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Deborah S Baker was code 99214 (office e&m - established), 107 times for 48 patients. In total Deborah S Baker billed 244 services in 6 codes, and Medicare paid $8,324.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2025-03-12.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 107 | 48 | $48.58 | $5,198 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 96 | 43 | $10.56 | $1,014 |
| 99213 Office E&M - Established | Office | 33 | 18 | $43.38 | $1,431 |
By year: 2022 $9,892 for 4,380 services; 2023 $13K for 2,276 services; 2024 $8,324 for 244 services.
Medicare prescription drug claims, 2024
In 2024, the drug Deborah S Baker prescribed most often to Medicare patients was Buspirone Hcl, with 268 prescriptions and refills. In total Deborah S Baker wrote 5,272 Medicare prescriptions that cost $2.7M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Buspirone Hcl Generic | 268 | 458 | 64 | $6,317 |
| Bupropion Xl Bupropion Hcl | 238 | 470 | 55 | $5,486 |
| Desvenlafaxine Succinate Er Desvenlafaxine Succinate | 190 | 338 | 40 | $20K |
| Rexulti Brexpiprazole | 188 | 215 | 32 | $306K |
| Trazodone Hcl Generic | 187 | 325 | 49 | $1,338 |
| Quetiapine Fumarate Generic | 178 | 337 | 39 | $4,151 |
| Aripiprazole Generic | 172 | 284 | 39 | $11K |
| Vraylar Cariprazine Hcl | 168 | 178 | 23 | $255K |
| Oxcarbazepine Generic | 151 | 229 | 22 | $13K |
| Duloxetine Hcl Generic | 149 | 318 | 34 | $4,466 |
| Gabapentin Generic | 144 | 180 | 30 | $1,830 |
| Venlafaxine Hcl Er Venlafaxine Hcl | 131 | 184 | 20 | $2,865 |
| Hydroxyzine Pamoate Generic | 130 | 163 | 19 | $3,385 |
| Belsomra Suvorexant | 129 | 137 | 34 | $60K |
| Hydroxyzine Hcl Generic | 121 | 169 | 38 | $3,520 |
Brand drugs: 1,080 claims; generic drugs: 4,192 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Deborah S Baker $1,849 ($1,849 in general payments such as food, travel and fees) from 16 companies. The largest payer was Teva Pharmaceuticals USA, Inc. with $316.
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. TEVA | 11 | $316 |
| E.R. Squibb & Sons, L.L.C. BMY | 22 | $288 |
| Vanda Pharmaceuticals Inc. VNDA | 14 | $156 |
| Abbvie Inc. ABBV | 9 | $151 |
| Lundbeck LLC | 9 | $146 |
| Alkermes, Inc. ALKS | 7 | $142 |
| Otsuka America Pharmaceutical, Inc. 4578.T | 6 | $117 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) JNJ | 5 | $101 |
| Tris Pharma Inc | 6 | $100 |
| Supernus Pharmaceuticals, Inc. SUPN | 4 | $73.96 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.